Truncated activin type II receptor inhibits erythroid differentiation in K562 cells
Truncated activin type II receptor inhibits erythroid differentiation in K562 cells
复制标题
截短的激活素 II 型受体抑制 K562 细胞红系分化
DOI:
--
复制
发表时间:
2000
影响因子:
4
通讯作者:
John Yu
中科院分区:
文献类型:
--
作者:
Fang Liu;L. Shao;John Yu
Two receptor serine/threonine kinases (types I and II) have been identified as signaling transducing activin receptors. We studied the possibility of inhibiting activin A‐dependent differentiation in K562 cells, using a dominant negative mutant of type II receptor. A vector was constructed expressing activin type II truncated receptor (ActRIIa) that lacks the cytoplasmic kinase domain. Since activin type I and II receptors form heteromeric complexes for signaling, the mutant receptors compete for binding to endogenous receptors, hence acting in a dominant negative fashion. K562 cells were stably transfected with ActRIIa, and independent clones were expanded. The truncated cDNA was integrated into the genome of the transfectants, as shown by polymerase chain reaction; and the surface expression of truncated receptors was shown by affinity cross‐linking with 125I‐activin A. In wild‐type K562 cells, activin A induced erythroid differentiation and cells started to express hemoglobins. In transfected cells expressing ActRIIa, the induction of erythroid differentiation was abrogated and less than 10% of cells were hemoglobin‐containing cells after culture with activin A. Further transfection with wild‐type type II receptors rescued the mutant phenotype of these transfectants, indicating that the effect of ActRIIa is dominant negative. In addition, phosphorylation of the cytoplasmic kinase domain of the type II receptor in vitro confirms the autophosphorylation of this portion of the receptor. Therefore, induction of erythroid differentiation in vitro is mediated through the cell surface activin receptor, and interference with this receptor signaling inhibits this process of differentiation in K562 cells. J. Cell. Biochem. 78:24–33, 2000. © 2000 Wiley‐Liss, Inc.
登录
查看更多内容
DOI:
10.1210/endo.136.12.7588300
发表时间:
1995
期刊:
Endocrinology.
影响因子:
--
作者:
Tsuchida,K;Vaughan,JM;Wiater,E;Gaddy-Kurten,D;Vale,WW
通讯作者:
Vale,WW
DOI:
10.1016/s0006-291x(88)80326-7
发表时间:
1988
影响因子:
3.1
作者:
Campen,CA;Vale,W
通讯作者:
Vale,W
DOI:
--
发表时间:
1993
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Mathews,LS;Vale,WW
通讯作者:
Vale,WW
影响因子:
2.6
作者:
Shao,L;FrigonJr,NL;Sehy,DW;Yu,AL;Lofgren,J;Schwall,R;Yu,J
通讯作者:
Yu,J
影响因子:
20.3
作者:
Yu,J;Shao,L;Vaughan,J;Vale,W;Yu,AL
通讯作者:
Yu,AL